Significance of E2F-1 overexpression in epithelial ovarian cancer
- 1 May 2008
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 18 (3) , 492-498
- https://doi.org/10.1111/j.1525-1438.2007.01044.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian CancerOncology, 2004
- Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients1 1Authors Hashiguchi and Tsuda contributed equally to this article.Human Pathology, 2004
- Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rateEuropean Journal Of Cancer, 2002
- Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survivalHuman Pathology, 2001
- Inverse Expression of Cdk4 and p16 in Epithelial Ovarian TumorsGynecologic Oncology, 2000
- The Concurrent Expression of p27kip1and Cyclin D1 in Epithelial Ovarian TumorsGynecologic Oncology, 1999
- Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancerInternational Journal of Cancer, 1997
- P 16 Overexpression: A potential early indicator of transformation in ovarian carcinomaJournal of the Society for Gynecologic Investigation, 1997
- NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian CancerJAMA, 1995